SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-094760
Filing Date
2024-04-12
Accepted
2024-04-12 16:31:29
Documents
7
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 PRE 14A d675436dpre14a.htm PRE 14A 440079
2 GRAPHIC g675436dsp001ajpg.jpg GRAPHIC 7825
3 GRAPHIC g675436dspp004a.jpg GRAPHIC 3442
4 GRAPHIC g675436dspp004b.jpg GRAPHIC 3062
5 GRAPHIC g675436g45t78.jpg GRAPHIC 46043
6 GRAPHIC g675436g75x49.jpg GRAPHIC 77642
7 GRAPHIC g675436g84s56.jpg GRAPHIC 75143
  Complete submission text file 0001193125-24-094760.txt   728636
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38443 | Film No.: 24841917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)